ARTICLE | Company News
Message other research news
October 26, 1998 8:00 AM UTC
Message received a $615,000 Phase II SBIR grant from the National Heart, Lung and Blood Institute to conduct drug discovery of HMGR inhibitors to treat atherosclerosis. HMGR is an enzyme involved in r...